Cortisol during the day in patients with systemic lupus erythematosus or primary Sjögren's syndrome

Journal of Rheumatology

Volumn 38, Issue 2, 2011, Pages 285-288

  Van Der Goes, Marlies C ^a   Bossema, Ercolie R ^c   Hartkamp, André ^a,b   Godaert, Guido L R ^c   Jacobs, Johannes W G ^a   Kruize, Aike A ^a   Derksen, Ronald H W M ^a   Bijlsma, Johannes W J ^a   Geenen, Rinie ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b JEROEN BOSCH HOSPITAL   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Adrenal cortex hormones; Hypothalamic hypophyseal system; Inflammation; Pituitary adrenal system; Sj gren's syndrome; Systemic lupus erythematosus

Indexed keywords

HYDROCORTISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; PRIORITY JOURNAL; SALIVA LEVEL; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TIME;

ADULT; AGED; ANALYSIS OF VARIANCE; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOASSAY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; SALIVA; SJOGREN'S SYNDROME;

EID: 79551699385     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100572     Document Type: Article

References (21)

1. Lechner O, Hu Y, Jafarian-Tehrani M, Dietrich H, Schwarz S, Herold M, et al. Disturbed immunoendocrine communication via the hypothalamo-pituitary- adrenal axis in murine lupus. Brain Behav Immun 1996;10:337-50. (Pubitemid 27116508)
2. Eskandari F, Webster JI, Sternberg EM. Neural immune pathways and their connection to inflammatory diseases. Arthritis Res Ther 2003;5:251-65. (Pubitemid 37407974)
3. Straub RH, Dhabhar FS, Bijlsma JW, Cutolo M. How psychological stress via hormones and nerve fibers may exacerbate rheumatoid arthritis. Arthritis Rheum 2005;52:16-26. (Pubitemid 40129228)
4. Kirschbaum C, Hellhammer DH. Salivary cortisol in psychological research: an overview. Neuropsychobiology 1989;22:150-69. (Pubitemid 20291714)
5. Perry MG, Kirwan JR, Jessop DS, Hunt LP. Overnight variations in cortisol, interleukin 6, tumour necrosis factor a and other cytokines in people with rheumatoid arthritis. Ann Rheum Dis 2009;68:63-8.
6. Dekkers JC, Geenen R, Godaert GL, van Doornen LJ, Bijlsma JW. Diurnal rhythm of salivary cortisol levels in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000;43:465-7.
7. Köller MD, Templ E, Riedl M, Clodi M, Wagner O, Smolen JS, et al. Pituitary function in patients with newly diagnosed untreated systemic lupus erythematosus. Ann Rheum Dis 2004;63:1677-80. (Pubitemid 39573703)
8. Gutiérrez MA, Garcia ME, Rodriguez JA, Rivero S, Jacobelli S. Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus. Lupus 1998;7:404-8. (Pubitemid 28410186)
9. Johnson EO, Vlachoyiannopoulos PG, Skopouli FN, Tzioufas AG, Moutsopoulos HM. Hypofunction of the stress axis in Sjögren's syndrome. J Rheumatol 1998;25:1508-14.
10. Johnson EO, Kostandi M, Moutsopoulos HM. Hypothalamic-pituitary-adrenal axis function in Sjögren's syndrome: mechanisms of neuroendocrine and immune system homeostasis. Ann NY Acad Sci 2006;1088:41-51. (Pubitemid 47092039)
11. Neeck G, Federlin K, Graef V, Rusch D, Schmidt KL. Adrenal secretion of cortisol in patients with rheumatoid arthritis. J Rheumatol 1990;17:24-9. (Pubitemid 20070562)
12. Boss B, Neeck G. Correlation of IL-6 with the classical humoral disease activity parameters ESR and CRP and with serum cortisol, reflecting the activity of the HPA axis in active rheumatoid arthritis. Z Rheumatol 2000;59 Suppl 2:II/62-4.
13. Hartkamp A, Geenen R, Godaert GLR, Bootsma H, Kruize AA, Bijlsma JW, et al. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial. Ann Rheum Dis 2008;67:91-7.
14. Hartkamp A, Geenen R, Godaert GLR, Bijl M, Bijlsma JWJ, Derksen RHWM. Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus. A randomized controlled trial. Ann Rheum Dis 2010;69:1144-7.
15. Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY, et al. Assessment of the European classification criteria for Sjogren's syndrome in a series of clinically defined cases: Results of a prospective multicentre study. Ann Rheum Dis 1996;55:116-21.
16. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
17. Dressendörfer RA, Kirschbaum C, Rohde W, Stahl F, Strassburger CJ. Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement. J Steroid Biochem Molec Biol 1992;43:683-92. (Pubitemid 23002501)
18. Tabachnick BG, Fidell LS. Using multivariate statistics. 5th ed. Boston: Allyn and Bacon; 2007.
19. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med 1995;333:142-6.
20. Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309-18.
21. Van Everdingen AA, Jacobs JW, Siewertsz Van Reesema DR, Bijlsma JW. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 2002;136:1-12.